Major bleeding risk and healthcare economic outcomes of non-valvular atrial fibrillation patients newly-initiated with oral anticoagulant therapy in the real-world setting

J Lin, J Trocio, K Gupta, J Mardekian… - Journal of medical …, 2017 - Taylor & Francis
Aims: This study compared the risk for major bleeding (MB) and healthcare economic
outcomes of patients with non-valvular atrial fibrillation (NVAF) after initiating treatment with …

[PDF][PDF] Major bleeding risk and healthcare economic outcomes of non-valvular atrial fibrillation patients newly-initiated with oral anticoagulant therapy in the real-world …

J Lin, J Trocio, K Gupta, J Mardekian… - JOURNAL OF …, 2017 - academia.edu
Aims: This study compared the risk for major bleeding (MB) and healthcare economic
outcomes of patients with non-valvular atrial fibrillation (NVAF) after initiating treatment with …

Major bleeding risk and healthcare economic outcomes of non-valvular atrial fibrillation patients newly-initiated with oral anticoagulant therapy in the real-world setting

J Lin, J Trocio, K Gupta, J Mardekian… - Journal of medical …, 2017 - pubmed.ncbi.nlm.nih.gov
Aims This study compared the risk for major bleeding (MB) and healthcare economic
outcomes of patients with non-valvular atrial fibrillation (NVAF) after initiating treatment with …

Major bleeding risk and healthcare economic outcomes of non-valvular atrial fibrillation patients newly-initiated with oral anticoagulant therapy in the real-world setting …

J Lin, J Trocio, K Gupta, J Mardekian… - Journal of Medical …, 2017 - europepmc.org
Aims This study compared the risk for major bleeding (MB) and healthcare economic
outcomes of patients with non-valvular atrial fibrillation (NVAF) after initiating treatment with …

[PDF][PDF] Major bleeding risk and healthcare economic outcomes of non-valvular atrial fibrillation patients newly-initiated with oral anticoagulant therapy in the real-world …

J Lin, J Trocio, K Gupta, J Mardekian… - JOURNAL OF …, 2017 - academia.edu
Aims: This study compared the risk for major bleeding (MB) and healthcare economic
outcomes of patients with non-valvular atrial fibrillation (NVAF) after initiating treatment with …